Potential limitations of microdystrophin gene therapy for Duchenne muscular dystrophy. [PDF]
Hart CC +6 more
europepmc +1 more source
Dystrophin-Deficient Muscular Dystrophy in a Family of Shiba Inu Dogs with a Complex Deletion Encompassing <i>DMD</i> Exon 5. [PDF]
Mcleay L +6 more
europepmc +1 more source
Prostaglandins limit nuclear actin rod formation during <i>Drosophila</i> oogenesis. [PDF]
Tootle TL.
europepmc +1 more source
Gene Editing for Duchenne Muscular Dystrophy: From Experimental Models to Emerging Therapies. [PDF]
Haque US, Yokota T, Yokota T.
europepmc +1 more source
3D-QSAR Modeling on 2-Pyrimidine Carbohydrazides as Utrophin Modulators for the Treatment of Duchenne Muscular Dystrophy by Combining CoMFA, CoMSIA, and Molecular Docking Studies. [PDF]
Mahmoudzadeh Laki R, Pourbasheer E.
europepmc +1 more source
Growth Hormone Secretagogue Receptor (GHSR) Is Elevated in Myocardial Tissues of DMD <i>mdx:utrn</i><sup>-/-</sup> Mice, and Correlates Strongly with Inflammatory Markers, and Negatively with Cardiac Function. [PDF]
Naghibosadat M +9 more
europepmc +1 more source
Targeting EP2 Receptor Improves Muscle and Bone Health in Dystrophin-/-/Utrophin-/- Double-Knockout Mice. [PDF]
Gao X +7 more
europepmc +1 more source
Gene therapy delivered micro-dystrophins co-localize with transgenic utrophin in dystrophic skeletal muscle fibers. [PDF]
Krishna S +7 more
europepmc +1 more source
Cryo-EM structure revealed a novel F-actin binding motif in a Legionella pneumophila lysine fatty acyltransferase. [PDF]
Zeng WW +4 more
europepmc +1 more source

